12.62BMarket Cap
21.91P/E TTM
Key Figures
165.450Open
171.740High
871.92KVolume
21.91P/E TTM
14.72P/E Dynamic
--Dividend TTM
1.13%Turnover Ratio
165.530Prev. Close
162.405Low
92.96MTurnover
15.94P/E Static
1.35P/B
0.00%Div Yield TTM
3.56%ROA
211.00052wk High
0.65Volume Ratio
791.47MNet Profit
77.15MShares
7.4645EPS TTM
1.26Beta
6.27%ROE
66.57052wk Low
5.64%Amplitude
18.83%Gross Margin
12.62BMarket Cap
-1.39Reward/Risk
3.14%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
ICON PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 58 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 187.27.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
ICON PLC Highlights
StrengthsRisks
ICON PLC News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Ionis Pharmaceuticals Inc
IONS
25
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
ICON PLC Info
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Ticker SymbolICLR
CompanyICON PLC
CEOBalfe (Barry Edward)
Websitehttps://www.iconplc.com/
Shareholders
FAQs
What is the current price of ICON PLC (ICLR)?
The current price of ICON PLC (ICLR) is 163.24.
What is the symbol of ICON PLC?
The ticker symbol of ICON PLC is ICLR.
What is the 52-week high of ICON PLC?
The 52-week high of ICON PLC is 211.00.
What is the 52-week low of ICON PLC?
The 52-week low of ICON PLC is 66.57.
What is the market capitalization of ICON PLC?
The market capitalization of ICON PLC is 12.59B.
Is ICON PLC (ICLR) currently rated as Buy, Hold, or Sell?
According to analysts, ICON PLC (ICLR) has an overall rating of Buy, with a price target of 187.27.
What is the Earnings Per Share (EPS TTM) of ICON PLC (ICLR)?
The Earnings Per Share (EPS TTM) of ICON PLC (ICLR) is 2.92.